Michael Yong
Overview
Explore the profile of Michael Yong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang M, Grimm D, Asmaro K, Yong M, Low C, Lee C, et al.
J Neurol Surg B Skull Base
. 2025 Jan;
86(1):76-81.
PMID: 39881739
Transpterygoid approaches to the skull base require dissection of the sphenopalatine artery, potentially compromising the option to harvest an ipsilateral nasoseptal flap (NSF) for reconstruction. In cases where other reconstructive...
2.
Grimm D, Qian Z, Yong M, Hwang P
Int Forum Allergy Rhinol
. 2024 Sep;
14(10):1675.
PMID: 39222268
No abstract available.
3.
Yong M, Hollemon D, Baxter J, Hirst A, Bryning S, Fox A, et al.
J Med Econ
. 2024 Apr;
27(1):708-714.
PMID: 38581156
Objective: To determine the economic impact of a minimally invasive temperature-controlled radiofrequency (TCRF) device for treating nasal airway obstruction (NAO). Methods: A budget impact model was developed for two scenarios:...
4.
Grimm D, Qian Z, Yong M, Hwang P
Int Forum Allergy Rhinol
. 2024 Feb;
14(7):1258-1260.
PMID: 38400591
PM2.5 exposure is a risk factor for the development of acute sinusitis. PM2.5 exposure affects acute sinusitis in a dose response fashion.
5.
Low C, Wang A, Yong M, Nayak J, Patel Z, Hwang P
Int Forum Allergy Rhinol
. 2024 Feb;
14(7):1249-1252.
PMID: 38297486
Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization...
6.
Yong M, Aravinthan K, Kirubalingam K, Thamboo A, Hwang P, Nadeau K, et al.
Laryngoscope
. 2023 Dec;
134(4):E14-E15.
PMID: 38153190
No abstract available.
7.
Yong M, Kirubalingam K, Desrosiers M, Kilty S, Thamboo A
Allergy Asthma Clin Immunol
. 2023 Oct;
19(1):90.
PMID: 37838713
Background: Dupilumab, omalizumab, and mepolizumab are the three biologics currently approved for use in CRSwNP in Canada. Despite evidence of efficacy, their cost-effectiveness, which is a key factor influencing prescribing...
8.
Luong A, Yong M, Hwang P, Lin B, Gopi P, Mohan V, et al.
Int Forum Allergy Rhinol
. 2023 Oct;
14(5):919-927.
PMID: 37812532
Background: Acoustic resonance therapy (ART) is a novel vibrational treatment that delivers patient-specific resonant frequency acoustic energy to the sinonasal cavities. In a pilot study, ART was effective for the...
9.
Yong M, Aravinthan K, Kirubalingam K, Thamboo A, Hwang P, Nadeau K, et al.
Laryngoscope
. 2023 Aug;
134(4):1572-1580.
PMID: 37642388
Background: Allergic rhinitis (AR) is a common condition that is frequently associated with atopic inferior turbinate hypertrophy (ITH) resulting in nasal obstruction. Current guidelines support the use of subcutaneous allergen...
10.
Emmett S, Platt A, Turner E, Gallo J, Labrique A, Meade Inglis S, et al.
Lancet Glob Health
. 2022 Jun;
10(7):e1023-e1033.
PMID: 35714630
Background: School-based programmes, including hearing screening, provide essential preventive services for rural children. However, minimal evidence on screening methodologies, loss to follow-up, and scarcity of specialists for subsequent care compound...